National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| NRC | NRC HEALTH | 2026-05-22 14:59:32 | 19.16 | 0.11 | 0.55 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRC | 0000070487 | NRC HEALTH | US6373722023 | 549300FQIORB6GZCYT15 | 470634000 | Nasdaq | 8731 | Services-Commercial Physical & Biological Research | 1231 | DE | 1245 Q STREET | LINCOLN | NE | 68508 | UNITED STATES | US | 4024752525 | 1245 Q STREET, LINCOLN, NE, 68508 | 1245 Q STREET, LINCOLN, NE, 68508 | NATIONAL RESEARCH CORP | — | 1981 | Michael D. Hays | 352 | http://nationalresearch.com/ | 194,764,382 | 31,975,649 | 22,536,696 | National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska. | 2026-05-21 17:49:03 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 194,764,382 | -104,633,653 | -34.948 | 22,536,696 | -408,836 | -1.7818 |
| 2024 | 299,398,035 | -231,664,227 | -43.6228 | 22,945,532 | -908,896 | -3.8102 |
| 2023 | 531,062,262 | 87,043,470 | 19.6036 | 23,854,428 | -739,962 | -3.0087 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Helen L. Hrdy | EVP, Chief Operating Officer | 2025 | 400,000 | 826,667 | 1,240,000 | 0 | 8,180 | 2,474,847 |
| Andy Monnich | Chief Corporate Development Officer, EVP | 2025 | 400,000 | 826,667 | 1,240,000 | 0 | 8,150 | 2,474,817 |
| Shane Harrison | Chief Financial Officer | 2025 | 92,308 | 100,000 | 2,287,600 | 0 | 1,192 | 2,481,100 |
| Trent Green | Chief Executive Officer | 2025 | 697,115 | 4,503,333 | 6,755,000 | 0 | 6,452 | 11,961,900 |
| Jason Rau | Executive Vice President | 2025 | 362,308 | 0 | 0 | 249,515 | 7,310 | 619,133 |
| Fiscal Year | Employee Count |
|---|---|
| 2019 | 464 |
| 2018 | 434 |
| 2017 | 430 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 137,390,000 | 143,060,000 | 148,580,000 |
| Cost Of Revenue | — | — | — |
| Gross Profit | 74,961,000 | 92,127,000 | 96,060,000 |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 54,805,000 | 44,911,000 | 46,621,000 |
| Operating Expenses | 52,371,000 | 56,933,000 | 56,015,000 |
| Operating Income | 22,590,000 | 35,194,000 | 40,045,000 |
| Net Income | 11,600,000 | 24,783,000 | 30,971,000 |
| Earnings Per Share Basic | 50 | 1.05 | 1.26 |
| Earnings Per Share Diluted | 50 | 1.04 | 1.25 |
| Weighted Average Shares Outstanding Basic | 22,383,000 | 23,703,000 | 24,540,000 |
| Weighted Average Shares Outstanding Diluted | 22,396,000 | 23,743,000 | 24,673,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 4,139,000 | 4,233,000 | 6,653,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 11,108,000 | 11,054,000 | 12,378,000 |
| Inventories | — | — | — |
| Non Trade Receivables | 528,000 | 141,000 | 161,000 |
| Other Assets Current | 520,000 | 692,000 | 940,000 |
| Total Assets Current | 20,209,000 | 19,600,000 | 24,360,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 40,474,000 | 38,269,000 | 28,205,000 |
| Other Assets Non Current | 3,318,000 | 2,713,000 | 3,274,000 |
| Total Assets Non Current | 114,669,000 | 108,664,000 | 98,077,000 |
| Total Assets | 134,878,000 | 132,539,000 | 122,437,000 |
| Accounts Payable | 1,169,000 | 1,194,000 | 1,301,000 |
| Deferred Revenue | 16,201,000 | 15,786,000 | 14,834,000 |
| Short Term Debt | 4,121,000 | 4,842,000 | 7,250,000 |
| Other Liabilities Current | 946,000 | 561,000 | 880,000 |
| Total Liabilities Current | 36,620,000 | 35,858,000 | 36,203,000 |
| Long Term Debt | 75,021,000 | 57,895,000 | 36,787,000 |
| Other Liabilities Non Current | 3,263,000 | 3,652,000 | 3,670,000 |
| Total Liabilities Non Current | 84,268,000 | 65,397,000 | 37,279,000 |
| Total Liabilities | 120,888,000 | 101,255,000 | 73,482,000 |
| Common Stock | 32,000 | 31,000 | 31,000 |
| Retained Earnings | -17,298,000 | -17,064,000 | -30,530,000 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | 13,990,000 | 31,284,000 | 48,955,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 7,624,000 | 6,022,000 | 5,899,000 |
| Share Based Compensation Expense | 3,312,000 | 284,000 | 935,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 53,000 | -1,757,000 | -2,084,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -24,000 | -1,749,000 | 1,767,000 |
| Change In Accounts Payable | 170,000 | -108,000 | 184,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 26,450,000 | 34,625,000 | 38,113,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 10,706,000 | 15,448,000 | 15,779,000 |
| Acquisition Of Business | — | 119,000 | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -10,706,000 | -20,281,000 | -15,778,000 |
| Tax Withholding For Share Based Compensation | 407,000 | 317,000 | 0 |
| Payments Of Dividends | 11,834,000 | 11,317,000 | 36,317,000 |
| Issuance Of Common Stock | 320,000 | 1,752,000 | 1,825,000 |
| Repurchase Of Common Stock | 20,180,000 | 30,945,000 | 19,099,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | 37,003,000 | 49,500,000 | 15,000,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -15,838,000 | -16,764,000 | -40,707,000 |
| Change In Cash | -94,000 | -2,420,000 | -18,373,000 |
| Cash At End Of Period | 4,139,000 | 4,233,000 | 6,653,000 |
| Income Taxes Paid | — | 8,225,000 | 8,932,000 |
| Interest Paid | 4,485,000 | 2,440,000 | 803,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 50 | 1.05 | 1.26 |
| Price To Earnings Ratio | 0.3754 | 16.8 | 31.3968 |
| Earnings Growth Rate | 4,661.9048 | -16.6667 | -1.5625 |
| Price Earnings To Growth Ratio | 0.0001 | -1.008 | -20.094 |
| Book Value Per Share | 0.625 | 1.3198 | 1.9949 |
| Price To Book Ratio | 30.0307 | 13.3653 | 19.8305 |
| Ebitda | 23,985,000 | 41,625,000 | 46,664,000 |
| Enterprise Value | 495,131,910 | 476,624,920 | 1,008,186,400 |
| Dividend Yield | 0.0282 | 0.0271 | 0.0374 |
| Dividend Payout Ratio | 1.0202 | 0.4566 | 1.1726 |
| Debt To Equity Ratio | 5.657 | 2.0054 | 0.8995 |
| Capital Expenditures | 9,829,000 | 16,086,000 | 16,856,000 |
| Free Cash Flow | 16,621,000 | 18,539,000 | 21,257,000 |
| Return On Equity | 0.8292 | 0.7922 | 0.6326 |
| One Year Beta | 0.7173 | 0.8859 | 0.5152 |
| Three Year Beta | 0.6994 | 0.5971 | 0.5917 |
| Five Year Beta | 0.6511 | 0.9765 | 0.9565 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Rau Jason Russell | Executive Vice President | 2026-03-12 | 60,000 | A | 60,000 |
| HARRISON SHANE R | EVP & Chief Financial Officer | 2026-02-17 | 8,000 | A | 8,000 |
| Bhandari Parul | Director | 2026-01-22 | 8,819 | A | 8,819 |
| Lockhart Stephen H | Director | 2026-01-22 | 8,819 | A | 8,819 |
| Hays Michael D. | Director, Chairman | 2026-01-05 | 9,145 | A | 20,154 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Sunbelt Securities, Inc. | 2026-03-31 | 187 | 11 | 17 |
| EverSource Wealth Advisors, LLC | 2026-03-31 | 18,305 | 1,078 | 16.9805 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2026-03-31 | 10,918 | 643 | 16.9798 |
| BANK OF AMERICA CORP /DE/ | 2026-03-31 | 1,909,706 | 112,468 | 16.98 |
| ALLIANCEBERNSTEIN L.P. | 2026-03-31 | 304,055 | 16,199 | 18.77 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Bridge Builder Trust | 2026-03-31 | Bridge Builder Small/Mid Cap Growth Fund | BBGSX | 2,318 | 39,359.64 | 0.0004 |
| Franklin Templeton ETF Trust | 2026-03-31 | Franklin U.S. Small Cap Multifactor Index ETF | FLQS | 1,078 | 18,304.44 | 0.0389 |
| EMPOWER FUNDS, INC. | 2026-03-31 | Institutional Class | MXTFX | 10,600 | 179,988 | 0.0313 |
| EMPOWER FUNDS, INC. | 2026-03-31 | Investor Class | MXLSX | 10,600 | 179,988 | 0.0313 |
| Series Portfolios Trust | 2026-03-31 | Acuitas Small Cap Active ETF | AIMS | 10,705 | 181,770.9 | 0.2479 |